$G

Nanduru Anil sold $229K of G

Nanduru Anil (Senior Vice President) sold 6,191 shares of Genpact LTD (G) at $37.03 ($0.23M total) on 2026-08-19.

Original reporting
SEC EDGAR · Nanduru Anil
Published Aug 20, 2026, 8:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$G
Neutral
high confidence
Mentioned
$G
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock, but it adds to the cumulative insider activity record.

02

Market read

A routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming earnings or strategic announcements not reflected in this filing.

Relevance 4/10Novelty 4/10Timing: filing on 2026-08-20 after market close

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$GNeutralHigh confidence
Context

Senior Vice President Nanduru Anil sold 6,191 shares of Genpact for $229K via an open‑market transaction.

Expected impact

Minimal short‑term impact; price likely unchanged.

Evidence & confidence

Sale size <$1M and insider is not a top executive; market typically absorbs such trades without significant movement.

Market effects

No broader sector impact; Genpact operates in business process services.

Limited to US equity markets where Genpact trades.

Low global relevance.

Counterpoint

If the insider expects a near‑term decline, the sale could signal downside risk.

Key entities

  • Genpact Ltd

    Global professional services firm (ticker G).

  • Nanduru Anil

    Senior Vice President at Genpact.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GMed

Genpact’s ED NOC Rejection Quashed: Karnataka HC Remands Matter for Fresh Decision on USD 100 Million GIFT City Investment

The Karnataka High Court overturned the Enforcement Directorate's rejection of Genpact's application for a No-Objection Certificate (NOC) for a $100 million investment in GIFT City, stating that ongoing investigations alone do not justify refusal. The court also vacated interim protection against the ED's seizure of Genpact's Gurgaon property. The case involves a 2015 restructuring of Genpact's Indian operations and alleged FEMA violations.

MedAI 8/10

Karnataka High Court upholds ED seizure order against Genpact

The Karnataka High Court upheld an Enforcement Directorate (ED) seizure order against Genpact India under FEMA, while quashing the ED's refusal to grant a no-objection certificate (NOC) for $100 million overseas remittance. The court found the refusal lacked adequate reasons and ordered a fresh decision within 10 days. The ED had accused Genpact of siphoning foreign exchange, but the court did not rule on the merits of the case.

$GMedAI 8/10

Karnataka HC upholds Genpact office seizure in ₹7,800-cr case

The Karnataka High Court upheld the seizure of Genpact India's Gurugram office by the Enforcement Directorate in a ₹7,800-crore money-routing case. The court also directed authorities to reconsider Genpact's $100-million investment proposal in GIFT City. The case involves transactions with Morgan Stanley and Genpact entities.

$GMed

Genpact Q2 Earnings Call Highlights

Genpact (NYSE:G) said it expects more than $1 billion in agentic total contract value in 2026, about 5x 2025. Management reported 3% net revenue growth and 300 bps gross-margin expansion from clients shifting to agentic delivery. Q2 gross margin rose to 36.5%, adjusted operating income was $234M, and adjusted EPS was $1.00. Genpact reaffirmed 2026 revenue growth of at least 7% and guided Q3 revenue to $1.369B-$1.382B.